Clonal cytogenetic abnormalities in patients with chronic myeloid leukemia in complete cytogenetic response to imatinib mesylate

被引：0
|
作者：
Espinet, Blanca [1 ,3 ]
Carla Oliveira, Ana [2 ]
Boque, Concepcion [2 ]
Domingo, Alicia [2 ]
Alonso, Esther [2 ]
Sole, Francesc [1 ,3 ]
机构：
[1] Hosp del Mar, Lab Citogenet & Biol Mol, Serv Patol, IMAS,URNHE PRBB, Barcelona, Spain
[2] Hosp Univ Bellvitge, Serv Hematol, ICO, Barcelona, Spain
[3] Escola Citol Hematol Soledad Woessner IMAS, Barcelona, Spain
来源：
HAEMATOLOGICA | 2005年 / 90卷 / 04期
关键词：
chronic myeloid leukemia; clonal cytogenetic abnormalities; imatinib;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The emergence of clonal chromosomal abnormalities in Philadelphia-negative cells during treatment with imatinib in patients with Philadelphia-positive chronic myeloid leukemia has been reported. We add information to this issue presenting a series of 29 patients in complete cytogenetic response after imatinib treatment, three of whom developed clonal aberrations.
引用
收藏
页码：556 / 558
页数：4
相关论文
共 50 条
  • [1] Acute myeloid leukemia developing during imatinib mesylate therapy for chronic myeloid leukemia in the absence of new cytogenetic abnormalities
    Pawarode, Attaphol
    Sait, Sheila N. J.
    Nganga, Alain
    Coignet, Lionel J.
    Barcos, Maurice
    Baer, Maria R.
    LEUKEMIA RESEARCH, 2007, 31 (11) : 1589 - 1592
  • [2] Prognostic Factors Associated with Complete Cytogenetic Response in Patients with Chronic Myelogenous Leukemia on Imatinib Mesylate Therapy
    Cojbasic, Irena
    Macukanovic-Golubovic, Lana
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2010, 138 (5-6) : 305 - 308
  • [3] Molecular remission in chronic myeloid leukemia patients with sustained complete cytogenetic remission after imatinib mesylate treatment
    Colombat, M
    Fort, MP
    Chollet, C
    Marit, G
    Roche, C
    Preudhomme, C
    Reiffers, J
    Praloran, V
    Mahon, FX
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2006, 91 (02): : 162 - 168
  • [4] Efficacy and safety of imatinib in patients with chronic myeloid leukemia and complete or near-complete cytogenetic response to interferon-α
    Branford, Susan
    Hughes, Timothy
    Milner, Alvin
    Koelmeyer, Rachel
    Schwarer, Anthony
    Arthur, Chris
    Filshie, Robin
    Moreton, Susan
    Lynch, Kevin
    Taylor, Kerry
    CANCER, 2007, 110 (04) : 801 - 808
  • [5] Early blastic transformation following complete cytogenetic response in a pediatric chronic myeloid leukemia patient treated with imatinib mesylate
    Morimoto, A
    Ogami, A
    Chiyonobu, T
    Takanashi, M
    Sugimoto, T
    Imamura, T
    Ishida, H
    Yoshihara, T
    Imashuku, S
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2004, 26 (05) : 320 - 322
  • [6] Sustained complete cytogenetic remission in a patient with chronic myeloid leukemia after discontinuation of imatinib mesylate therapy
    Seiichi Okabe
    Tetsuzo Tauchi
    Yuko Ishii
    Daigo Akahane
    Kousuke Nunoda
    Seiko Honda
    Tomoiku Takaku
    Kazuma Ohyashiki
    International Journal of Hematology, 2007, 85 : 173 - 174
  • [7] Risk and early cytogenetic response to imatinib and interferon in chronic myeloid leukemia
    Rosti, G
    Trabacchi, E
    Bassi, S
    Bonifazi, F
    De Vivo, A
    Martinelli, G
    Alberti, D
    Fincato, G
    Saglio, G
    Baccarani, M
    HAEMATOLOGICA, 2003, 88 (03) : 256 - 259
  • [8] CYTOGENETIC CLONAL EVOLUTION IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA
    Tarkan-Arguden, Y.
    Ar, M. Cem
    Yilmaz, S.
    Ongoren, S.
    Kuru, D.
    Ure, U.
    Cirakoglu, A.
    Eskazan, A. E.
    Guven, G. S.
    Cetin, G.
    Purisa, S.
    Baslar, Z.
    Deviren, A.
    Aydin, Y.
    Hacihanefioglu, S.
    Ferhanoglu, B.
    Tuzuner, N.
    Ulku, B.
    Soysal, T.
    BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT, 2009, 23 (04) : 1515 - 1520
  • [9] Factors predicting molecular and cytogenetic response in chronic myeloid leukemia patients treated with imatinib
    Roche-Lestienne, C
    Darré, S
    Laï, DL
    Facon, T
    Guilhot, J
    Preudhomme, C
    HAEMATOLOGICA, 2005, 90 (01) : 131 - 133
  • [10] Very late relapse in a patient with chronic myeloid leukemia in sustained complete cytogenetic response under imatinib
    Defina, M.
    Gozzetti, A.
    Rondoni, M.
    Aprile, L.
    Ippoliti, M.
    Chitarrelli, I.
    Lauria, F.
    Bocchia, M.
    LEUKEMIA RESEARCH, 2010, 34 (08) : E215 - E216
12345